CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (4732)
Allon Therapeutics Inc. is a clinical-stage biotechnology company developing treatments for major neurodegenerative conditions. Allon has 3 Phase II human efficacy trials underway pursuing three large underserved markets: Alzheimer's disease, schizop...Show all
Company (Acquired)
Phone:
1168 Hamilton Street
Suite 506
Vancouver, V6B 2S2
British Columbia, Canada
| Total Funding | Date of Last Funding | |
|---|---|---|
| Allon Therapeutics | $2.5M | Sep 10, 2004 |
| Intarcia Therapeutics | $1513.7M | Apr 3, 2017 |
| Celera Genomics | $0M | May 17, 2011 |
| See all 15 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Neuroprotection using nap-like and sal-like peptide mimetics | Feb 18, 2010 | Dec 04, 2012 | Patent |
| Use of adnf polypeptides for treating peripheral neurotoxicity | Oct 03, 2008 | Mar 27, 2012 | Patent |
Download PDF